Literature DB >> 431042

Experimental allergic neuritis. Ultrastructure of serum-induced myelin aberrations in peripheral nervous system cultures.

C S Raine, M B Bornstein.   

Abstract

Mature myelinated cultures of mouse dorsal root ganglia (sometimes grown in combination with spinal cord tissue) have been exposed to unheated and heated (complement-inactivated) serum from rabbits with experimental allergic neuritis (EAN). Experimental cultures were examined for periods ranging from several hours to approximately 2 weeks of exposure. Some cultures were exposed to EAN serum for approximately 1 week then returned to normal medium for examination of the reversibility of the lesions. Unheated EAN serum induced demyelination of peripheral nervous system fibers within 96 hours of exposure. Following removal of the EAN serum, affected fibers remyelinated. Heated EAN serum produced a type of myelin swelling identical with that described previously in spinal cord explants exposed to serum from rabbits with experimental allergic encephalomyelitis. The lamellar spacing of the peripheral nervous system meylin was increased to approximately 23 nm. and the normal bifilar intraperiod line was increased to four leaflets. Some hypermyelination was seen. The swelling was incompletely reversible following removal of the heated serum. These findings are discussed in terms of their relevance to immunemediated demyelination and peripheral neuropathy associated with the hypergammaglobulinemic states.

Entities:  

Mesh:

Year:  1979        PMID: 431042

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  20 in total

1.  Hereditary neuropathy with liability to pressure palsies: the same molecular defect can result in diverse clinical presentation.

Authors:  E Andreadou; C Yapijakis; G P Paraskevas; P Stavropoulos; C Karadimas; V P Zis; P Davaki; N Karandreas; M Rentzos; C Tsakanikas; D Vassilopoulos; C Papageorgiou
Journal:  J Neurol       Date:  1996-03       Impact factor: 4.849

Review 2.  Monoclonal antibodies to myelin-associated glycoprotein reveal antigenic structures and suggest pathogenic mechanisms.

Authors:  A J Steck; N Murray
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Polyneuropathy in Waldenström's macroglobulinaemia: reduction of endoneurial IgM-deposits after treatment with chlorambucil and plasmapheresis.

Authors:  C Meier; K Roberts; A Steck; C Hess; E Miloni; L Tschopp
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

4.  The occurrence and significance of myelin with unusually large periodicity.

Authors:  R H King; P K Thomas
Journal:  Acta Neuropathol       Date:  1984       Impact factor: 17.088

5.  Passive transfer of demyelination by experimental allergic neuritis serum.

Authors:  A F Hahn; J J Gilbert; T E Feasby
Journal:  Acta Neuropathol       Date:  1980       Impact factor: 17.088

6.  Demyelination and remyelination in spinal cord lesions of human lymphotropic virus type I-associated myelopathy.

Authors:  E Ohama; Y Horikawa; T Shimizu; T Morita; K Nemoto; H Tanaka; F Ikuta
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

7.  Acute inflammatory demyelinating polyneuropathy in a diabetic patient: predominance of vesicular disruption in myelin sheaths.

Authors:  C Vital; C Brechenmacher; J P Cardinaud; G Manier; A Vital; B Mora
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

8.  Spinal cord dysmyelination caused by an antiproteolipid protein IgM antibody: implications for the mechanism of central nervous system myelin formation.

Authors:  J Rosenbluth; R Schiff
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

9.  The treatment of inflammatory polyneuropathy by plasma exchange.

Authors:  M L Gross; N J Legg; M C Lockwood; C Pallis
Journal:  J Neurol Neurosurg Psychiatry       Date:  1982-08       Impact factor: 10.154

10.  Blood-nerve barrier studies in experimental allergic neuritis.

Authors:  A F Hahn; T E Feasby; J J Gilbert
Journal:  Acta Neuropathol       Date:  1985       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.